Skip to main content

Advertisement

SpringerLink
Log in

The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant problem in many healthcare systems. In Germany, few data are available on its economic consequences and, so far, no study has been performed using a large sample of real-life data from several hospitals. We present a retrospective matched-pairs analysis of mortality, length of stay, and cost of MRSA patients based mainly on routine administrative data from 11 German hospitals. Our results show that MRSA patients stay in hospital 11 days longer, exhibit 7% higher mortality, are 7% more likely to undergo mechanical ventilation, and cause significantly higher total costs (€ 8,198).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. Our data set consists of hospital stays, not patients. In the G-DRG system, there are elaborate rules that result in two cases being merged into one if they occur within a short timeframe and are either likely to be caused by the same underlying condition or if the second is likely to be caused by complications incurred during the first stay. Cases that were merged according to these rules were excluded from the analysis to avoid contamination with this problem and because no 100% clear-cut length of stay can be determined. Thus, the remaining cases can be regarded as independent for the purpose of our analyses.

  2. This figure varied between 4.1 and 92.3% across the surveyed hospitals.

  3. The maximum proportion of U80.0!-codes without a positive laboratory result was 0.3%.

  4. This figure is slightly lower than the 0.56% that can be computed from data supplied by the National Reference Centre for the Surveillance of Nosocomial Infections based on reports from 65 hospitals [17].

  5. Apart from the mean difference, we also looked at boxplots of the distributions, and compared the distributions using the Kolmogorov–Smirnov and the Mann–Whitney U Tests. These results pointed in the same direction and are thus not reproduced here.

  6. The percentage of bias reduction should be as equal as possible over the covariates, as otherwise bias may be increased for some function of these covariates, even if univariate bias has been reduced for each of them. This property is known as “equal percentage bias reducing” or EPBR [22].

  7. Here, we are at odds with Ho et al. [14], who claim that the choice of the matching algorithm is merely a mechanical decision of picking the one with the lowest bias (i.e. the best balance). This would require knowledge of which variables best represent the universe of the relevant pretreatment covariates—known to be measured or not. Also, there is more than one criterion for assessing the quality of the matching, and these do not always point in the same direction. The outcome, it is claimed, has no part to play in the decision as this could lead to “stacking the deck”. While this danger is real, in our view the decision for one matching algorithm will always involve some judgment—even with regard to the plausibility of the estimated effects. Here, we present the results of different datasets to make the influence of our decision on the reported results as transparent as possible.

  8. We have chosen to carry out this subgroup analysis because MV is generously reimbursed in the G-DRG system. As reimbursement is based on average cost across the German hospital system, we decided that this subgroup merits closer analysis. MV is potentially associated with higher costs in a number of ways:

    (1) MV increases length of stay.

    (2) MV is an indicator of a more severe course of disease and is thus potentially associated with increased LOS and higher treatment costs.

    (3) MV is a potential cause of nosocomial infection and its associated costs.

    (4) According to G-DRG cost accounting regulations, some cost (nurses and medical technology) are apportioned to patients with mechanical ventilation using a much higher weighting factor for hours (e.g. 1.71) as compared to treatment (e.g. 1) or monitoring hours (e.g. 0.57) [6].

    Unfortunately, in our retrospective study, we can neither determine the relative importance of these influences nor the direction of causation.

  9. Subgroups were analysed only in matching 1 for reasons of sample size. Also, we deem these results more accurate and thus present results from the second matching only to demonstrate the robustness of our overall results.

References

  1. Austin, P.C., Mamdani, M.M., Stukel, T.A., Anderson, G.M., Tu, J.V.: The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat. Med. 24, 1563–1578 (2005). doi:10.1002/sim.2053

    Article  Google Scholar 

  2. Cochran, W.G.: The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24, 295–313 (1968). doi:10.2307/2528036

    Article  Google Scholar 

  3. Coia, J.E.: Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J. Hosp. Infect. 63(Suppl 1), S1–S44 (2006)

    Article  Google Scholar 

  4. Cosgrove, S.E., Carmeli, Y.: The impact of antimicrobial resistance on health and economic outcomes. Clin. Infect. Dis. 36, 1433–1437 (2003). doi:10.1086/375081

    Article  Google Scholar 

  5. Deutsche Krankenhausgesellschaft (DKG): Spitzenverbände der Krankenkassen (GKV), Verband der privaten Krankenversicherung (PKV), Institut für das Entgeltsystem im Krankenhaus (InEK gGmbH): Deutsche Kodierrichtlinien: Allgemeine und Spezielle Kodierrichtlinien für die Verschlüsselung von Krankheiten und Prozeduren. Version 2004. Institut für das Entgeltsystem im Krankenhaus, Siegburg (2003)

  6. Deutsche Krankenhausgesellschaft (DKG), Spitzenverbände der Krankenkassen (GKV), Verband der privaten Krankenversicherung (PKV): KALKULATION VON FALLKOSTEN: Handbuch zur Anwendung in Krankenhäusern. Version 2.0 (2002)

  7. European Antimicrobial Resistance Surveillance System (EARSS): EARSS Annual Report 2006, Bilthoven, (2007)

  8. Gastmeier, P., Daschner, F., Rüden, H.: Surveillance von nosokomialen Infektionen mit dem Krankenhaus-Infektions-Surveillance-System (KISS) lohnt sich. Krankenhaus 97, 119–122 (2005)

    Google Scholar 

  9. Gastmeier, P., Sohr, D., Geffers, C., Behnke, H., Daschner, F., Rüden, H.: Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German nosocomial infection surveillance system (KISS). Infection 33, 50–55 (2005). doi:10.1007/s15010-005-3186-5

    Article  Google Scholar 

  10. Geldner, G., Ruoff, M., Hoffmann, H.-J., Kiefer, P., Georgieff, M., Wiedeck, H.: Eine Kostenanalyse von MRSA-Infektionen auf einer operativen Intensivstation. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 34, 409–413 (1999). doi:10.1055/s-1999-10830

    Article  Google Scholar 

  11. Gould, I.M.: The clinical significance of methillicin-resistant Staphylococcus aureus. J. Hosp. Infect. 61, 277–282 (2005). doi:10.1016/j.jhin.2005.06.014

    Article  Google Scholar 

  12. Greiner, W., Rasch, A., Köhler, D., Salzberger, B., Fätkenheuer, G., Leidig, M.: Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. Clin. Microbiol. Infect. 13, 264–268 (2007). doi:10.1111/j.1469-0691.2006.01622.x

    Article  Google Scholar 

  13. Herr, C.E., Heckrodt, T.H., Hofmann, F.A., Schnettler, R., Eikmann, T.F.: Additional cost for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these cost on a surgical ward. Infect. Control Hosp. Epidemiol. 24, 673–678 (2003). doi:10.1086/502274

    Article  Google Scholar 

  14. Ho, D., Imai, K., King, G., Stuart, E.: Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit. Anal. 15, 199–236 (2007). doi:10.1093/pan/mpl013

    Article  Google Scholar 

  15. Kreienbrock, L., Schach, S.: Epidemiologische Methoden, 4th edn. Spektrum, Heidelberg (2005)

    Google Scholar 

  16. Lemmen, S.W., Zolldann, D., Häfner, H., Lütticken, R., Koch, S.: Einfluss der klinischen Infektiologie. Nicht nur multiresistente Erreger sondern auch die Kosten in Schach halten. Klinikarzt 33, 21–24 (2004). doi:10.1055/s-2004-819024

    Article  Google Scholar 

  17. Nationales Referenzzentrum für Surveilance von Nosokomialen Infektionen (NRZ): KISS Krankenhaus-Infektions-Surveillance-System, Modul: MRSA-KISS 2004, Abschnitt A.1—Referenzdaten Gesamt (2005)

  18. Nathwani, D.: Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter? J. Antimicrob. Chemother. 51(Suppl S2), ii37–ii44 (2003)

    Google Scholar 

  19. Noskin, G.A., Rubin, R.J., Schentag, J.J., Kluytmans, J., Hedblom, E.C., Smulders, M., Laptina, E., Gemmen, E.: The burden of Staphylococcus aureus infections on hospitals in the United States. An analysis of the 2000 and 2001 nationwide inpatient sample database. Arch. Intern. Med. 165, 1756–1761 (2005). doi:10.1001/archinte.165.15.1756

    Article  Google Scholar 

  20. Regierung der Bundesrepublik Deutschland: Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Frank Spieth, Klaus Ernst, Dr. Martina Bunge, Katja Kipping und der Fraktion DIE LINKE. Drucksache 16/2942—Ausbreitung multiresistenter Keime in deutschen Kliniken und Strategien dagegen. In: Deutscher Bundestag, Bundestagsdrucksache 16/3205, October 30, (2006)

  21. Robert Koch Institut (RKI): Merkblätter für Ärzte. Staphylokokken-Erkrankungen, insbesondere Infektionen durch MRSA. Epidemiologisches Bulletin 08/2000, amended and updated, February 2007

  22. Rubin, D.B.: Multivariate matching methods that are equal percentage bias reducing, I. Some examples. Biometrics 32, 109–120 (1976)

    Article  Google Scholar 

  23. Stausberg, J., Lehmann, N., Kaczmarek, D., Stein, M.: Einheitliches Kodieren in Deutschland: Wunsch und Wirklichkeit. Krankenhaus 97, 657–662 (2005)

    Google Scholar 

  24. Vriens, M., Blok, H., Fluit, A., Troelstra, A., Van Der Werken, C., Verhoef, J.: Cost associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur. J. Clin. Microbiol. Infect. Dis. 21, 782–786 (2002). doi:10.1007/s10096-002-0811-4

    Article  Google Scholar 

  25. Wernitz, M.H., Keck, S., Swidsinski, S., Schulz, S., Veit, S.K.: Cost analysis of a hospital-wide selective screening programme for methicillin resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin. Microbiol. Infect. 11, 466–471 (2005). doi:10.1111/j.1469-0691.2005.01153.x

    Article  Google Scholar 

Download references

Acknowledgement

The research presented in this article was financed by Pfizer Deutschland GmbH.

Author information

Authors and Affiliations

  1. Im Nonnengarten 49, 67098, Bad Dürkheim, Germany

    Ansgar Resch

  2. Dr. Wilke GmbH, Werner-Eckert-Str. 12, 81829, Munich, Germany

    Michael Wilke

  3. Rambøll Management GmbH, Saarbrücker Straße 20/21, 10405, Berlin, Germany

    Christian Fink

Authors
  1. Ansgar Resch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Wilke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Fink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Resch, A., Wilke, M. & Fink, C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 10, 287–297 (2009). https://doi.org/10.1007/s10198-008-0132-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-008-0132-3

Keywords

JEL Classification

Search

Navigation